OBI Pharma Signs Collaboration and License Agreement with Novartis
2026.Oct.07
News
Following Presidential Office Recognition, OBI Pharma Showcases the Strength of Its Obrion® ADC Platform and Accelerates Global Licensing to Capture Expanding Market Opportunities
2026.Jul.06
News
OBI Pharma’s Obrion® ADC Technology Platform Wins Product Innovation of the Year at the 2026 Taiwan BIO Awards